Evidence map›Paper›PMID 20855536›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2010

Germline variation in apoptosis pathway genes and risk of non-Hodgkin's lymphoma.

Jennifer L Kelly, Anne J Novak, Zachary S Fredericksen, Mark Liebow, Stephen M Ansell, Ahmet Dogan, Alice H Wang, Thomas E Witzig, Timothy G Call, Neil E Kay and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Bim polymorphisms: influence on function and response to treatment in children with acute lymphoblastic leukemia.Clinical cancer research : an official journal of the American Association for Cancer Research · 2013
    Article
  18. Caspase functions in cell death and disease.Cold Spring Harbor perspectives in biology · 2013
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Jennifer L KellySchool of Medicine and Dentistry, University of Rochester, Rochester, New York, USA.
Anne J Novak
Zachary S Fredericksen
Mark Liebow
Stephen M Ansell
Ahmet Dogan
Alice H Wang
Thomas E Witzig
Timothy G Call
Neil E Kay
Thomas M Habermann
Susan L Slager
James R Cerhan
University of Rochester · USMayo Clinic in Florida · US

Funding

Molecular Epidemiology of NHL and CLLR01CA092153 · NCI · MAYO CLINIC ROCHESTER · PI CERHAN, JAMES R · 2003 to 2012
$6.7M
HEMATOLOGY RESEARCHT32HL007152 · NHLBI · UNIVERSITY OF ROCHESTER · PI FRANCIS, CHARLES W. · 1985 to 2011
$2.1M
NCI NIH HHS R01 CA092153NCI NIH HHS R01 CA92153NHLBI NIH HHS HL007152NHLBI NIH HHS T32 HL007152
6 · The paper itself

Abstract

backgroundThe t(14;18)(q32;q21) translocation is the most commonly observed chromosomal translocation in non-Hodgkin's lymphoma (NHL), resulting in constitutive Bcl-2 expression and apoptosis inhibition. In addition, germline variation in both BCL2L11 (BIM) and CASP9, known regulators of apoptosis, has recently been linked to NHL risk. We conducted a comprehensive evaluation of 36 apoptosis pathway genes with risk of NHL.

methodsWe genotyped 226 single-nucleotide polymorphisms (SNP) from 36 candidate genes in a clinic-based study of 441 newly diagnosed NHL cases and 475 frequency-matched controls. We used principal components analysis to assess gene-level associations, and logistic regression to assess SNP-level associations. MACH was used for imputation of SNPs in BCL2L11 and CASP9.

resultsIn gene-level analyses, BCL2L11 (P = 0.0019), BCLAF1 (P = 0.0097), BAG5 (P = 0.026), and CASP9 (P = 0.0022) were associated with NHL risk after accounting for multiple testing (tail strength, 0.38; 95% confidence interval, 0.05-0.70). Two of the five BCL2L11 tagSNPs (rs6746608 and rs12613243), both genotyped BCLAF1 tagSNPs (rs797558 and rs703193), the single genotyped BAG5 tagSNP (rs7693), and three of the seven genotyped CASP9 tagSNPs (rs6685648, rs2020902, and rs2042370) were significant at P < 0.05. We successfully imputed BCL2L11 and CASP9 SNPs previously linked to NHL, and replicated all four BCL2L11 and two of three CASP9 SNPs.

conclusionWe replicated the association of BCL2L11 and CASP9 with NHL risk at the gene and SNP level, and identified novel associations with BCLAF1 and BAG5. IMPACT: Closer evaluation of germline variation of genes in the apoptosis pathway with risk of NHL and its subtypes is warranted.

Indexed as

Adaptor Proteins, Signal TransducingApoptosisApoptosis Regulatory ProteinsBcl-2-Like Protein 11Carrier ProteinsCase-Control StudiesCaspase 9FemaleGenetic Predisposition to DiseaseHumansLymphoma, Non-HodgkinMaleMembrane ProteinsMiddle AgedPolymorphism, Single NucleotideProto-Oncogene ProteinsAdaptor Proteins, Signal TransducingApoptosis Regulatory ProteinsBAG5 protein, humanBCL2L11 protein, humanBcl-2-Like Protein 11BCLAF1 protein, humanCarrier ProteinsCASP9 protein, humanCaspase 9Membrane ProteinsProto-Oncogene ProteinsRepressor ProteinsTumor Suppressor Proteins

Identifiers

PMID20855536
PMCPMC2976783
OpenAlexW2140558141

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.